Table 1 Demographic and clinical characteristics of rheumatoid arthritis and gout synovial tissue immunohistochemistry
From: FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis
|  | Rheumatoid arthritis (n = 15) | Gout (n = 12) |
|---|---|---|
Age (years) | 56 ± 13 | 74 ± 17 |
Sex, female/male | 13/3 | 2/10 |
Disease duration (years) | 10.3 ± 14.4 | 2.2 ± 3.5 |
Swollen joint count | 7 ± 5 | 2 ± 3 |
C-reactive protein (mg/l) | 26.6 ± 21.2 | 18.2 ± 17.75 |
Disease Activity Score in 28 joints | 5.0 ± 1.2 | nd |
Erythrocyte sedimentation rate (mm/hour) | 40.2 ± 30.3 | 27.7 ± 19.2 |
IgM-RF (kU/l) | 493 ± 1406 | nd |
Anti-CCP (kAU/ml) | 2472 ± 3600 | nd |
Number taking NSAIDS (positive/negative) | 9/15 | 5/12 |
Number taking corticosteroids (positive/negative) | 0/15 | 0/12 |
Number taking DMARDs (positive/negative) | 0/15 | 0/12 |
Number taking anti-tumor necrosis factor (positive/negative) | 0/15 | 0/12 |